Symbol Insights

You can receive insights into any symbol that we track. You'll see relevant statistics, signals, pricing data, etc.

Insights for AbbVie Inc.
New York Stock Exchange: ABBV
10 - Losing Steam - profitable but cannot fund turnaround
Sector: Health & Fitness
Industry: Medicine - Production & Distribution
Today's Price
updated on: 		190.6 (-1.23%)
Open 193.16 (-1.33%)
High (Upside %) 193.86 (1.71%)
Low (Downside %) 190.435 (0.09%)
P. Close 192.97 (-1.23%)
Open-High % 0.36%
Open-Low % 1.41%
Low-High % 1.8%
Active Buy Quantity 0
Active Sell Quantity 0
% Overtraded
Current Mood bearish
Previous Data
data from:
Open-High % 0.36%
Open-Low % 1.41%
Low-High % 1.8%
Open-Close % -1.33%
Low-Close % 0.09%
High-Close % 1.68%

ABBV is a Stock listed in the US on the New York Stock Exchange under the ticker 'ABBV'

Company Profile

AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals worldwide. The company offers Humira, an injection for autoimmune and intestinal Behçet's diseases, and pyoderma gangrenosum; Skyrizi to treat moderate to severe plaque psoriasis, psoriatic disease, and Crohn's disease; Rinvoq to treat rheumatoid and psoriatic arthritis, ankylosing spondylitis, atopic dermatitis, axial spondyloarthropathy, ulcerative colitis, and Crohn's disease; Imbruvica for the treatment of adult patients with blood cancers; Epkinly to treat lymphoma; Elahere to treat cancer; and Venclexta/Venclyxto to treat blood cancers. It also provides facial injectables, plastics and regenerative medicine, body contouring, and skincare products; botox therapeutic; Vraylar for depressive disorder; Duopa and Duodopa to treat advanced Parkinson's disease; Ubrelvy for the acute treatment of migraine in adults; and Qulipta for episodic and chronic migraine. In addition, the company offers Ozurdex for eye diseases; Lumigan/Ganfort and Alphagan/Combigan for the reduction of elevated intraocular pressure in patients with open angle glaucoma or ocular hypertension; Restasis to increase tear production; and other eye care products. Further, it provides Mavyret/Maviret to treat chronic hepatitis C virus genotype 1-6 infection; Creon, a pancreatic enzyme therapy; Lupron to treat advanced prostate cancer, endometriosis and central precocious puberty, and patients with anemia caused by uterine fibroids; Linzess/Constella to treat irritable bowel syndrome with constipation and chronic idiopathic constipation; and Synthroid for hypothyroidism. It has collaborations with Calico Life Sciences LLC; REGENXBIO Inc.; Janssen Biotech, Inc.; and Genentech, Inc., as well as collaboration with Tentarix Biotherapeutics, LP to develop conditionally-active and multi-specific biologics for oncology and immunology. The company was incorporated in 2012 and is headquartered in North Chicago, Illinois.

source:https://finance.yahoo.com/ABBV/profile

Predicted Prices
Key Low (open) Low (high) Close-Down (open) Close-Down (high) Close-Up (open) Close-Up (low) High (open) High (low)
Low Volatility 192.62
42.51% hit 		191.52
55.04% hit 		191.9
15.45% hit 		193.07
44.89% hit 		193.89
17.51% hit 		191.61
46.42% hit 		193.68
41.31% hit 		192.76
55.04% hit
Average Volatility 191.37
31.9% hit 		189.49
35.68% hit 		191.01
13.79% hit 		191.85
31.03% hit 		195.76
14.59% hit 		193.41
32.03% hit 		196.17
30.64% hit 		194.83
35.68% hit
High Volatility 188.56
3.12% hit 		183.87
3.18% hit 		189.46
3.05% hit 		187.78
3.25% hit 		200.76
3.78% hit 		199.26
3.58% hit 		202.29
3.91% hit 		200.78
3.18% hit

ABBV's predicted prices using open from of 193.16 and data until date . Current Price is 190.6

Basic Stats
Market Cap-Display Market Cap-Actual Market Cap Enterprise Value-Display Enterprise Value-Actual Enterprise Value Trailing P/E Forward P/E PEG Ratio (5yr expected) Price/Sales Price/Book Enterprise Value/Revenue Enterprise Value/EBITDA Profit Margin Operating Margin Return on Assets Return on Equity Revenue-Display Revenue-Actual Revenue Quarterly Revenue Growth EBITDA-Display EBITDA-Actual EBITDA Diluted EPS Quarterly Earnings Growth Total Cash-Display Total Cash-Actual Total Cash Total Debt-Display Total Debt-Actual Total Debt Total Debt/Equity Current Ratio Operating Cash Flow-Display Operating Cash Flow-Actual Operating Cash Flow Levered Free Cash Flow-Display Levered Free Cash Flow-Actual Levered Free Cash Flow % Held by Insiders % Held by Institutions
308.91 B 308910000000.0 308.91 372.71 B 372710000000.0 372.71 60.91 14.58 0.41 5.58 51.21 6.71 20.45 9.22% 28.93% 7.72% 56.41% 55.53 B 55530000000.0 55.53 3.80% 25.63 B 25630000000.0 25.63 2.87 -12.20% 7.29 B 7290000000.0 7.29 71.32 B 71320000000.0 71.32 11.748099999999999 0.64 16.51 B 16510000000.0 16.51 17.74 B 17740000000.0 17.74 0.10% 73.46%

source:https://finance.yahoo.com/ABBV/key-statistics

Reading Information

source:https://finance.yahoo.com/ABBV/key-statistics

source:https://www.google.com/finance/quote/ABBV:NYSE

source:https://finance.yahoo.com/ABBV/analysis

source:https://finance.yahoo.com/ABBV/fair-value

Upside-Downside Spread
Key Weighted 5D 1M 3M 6M 1Y 3Y 10Y
Upside % (high) 4.29% 2.04% (194.49) 2.04% (194.49) 8.16% (206.15) 8.77% (207.32) 8.77% (207.32) 8.77% (207.32) 8.77% (207.32)
Downside % (low) 11.48% 4.43% (182.15) 11.83% (168.06) 14.06% (163.81) 14.06% (163.81) 19.42% (153.58) 31.29% (130.96) 76.15% (45.45)
Spread % -7.19% -2.39% -9.78% -5.9% -5.28% -10.65% -22.52% -67.38%

ABBV's price used for computing the stats is 190.6 as on date

Cumulative Return Percent
Key Today 5D 1M 3M 6M 1Y 3Y 10Y
Last Price-Trend PrevClose 0.0% 3.64% 5.83% -6.51% 2.05% 9.99% 37.5% 214.0%
Last Price 190.6 190.6 190.6 190.6 190.6 190.6 190.6 190.6
Trend-Previous Close 190.6 183.9 180.1 203.87 186.78 173.29 138.62 60.7

ABBV's symbol cumulative return percent is computed basis data from date

Return Velocity
5D 2W 1M 3M 6M 1Y
5D window
Metric Mean Median Stdev
Overall 7.81% 8.66% 2.5%
Up 8.09% 8.77% 1.98%
Down -0.24% 0% 0.53%
5D Opportunity:
returns: 3.64% (10.07%), p.close: 183.9
entry: 202.42, exit: 204.42, return: -0.99%
Metric Mean Median Stdev
Overall 5.79% 5.56% 3.18%
Up 6.22% 6.21% 2.77%
Down -0.47% 0% 0.74%
5D Opportunity:
returns: 3.64% (9.0%), p.close: 183.9
entry: 200.45, exit: 199.98, return: 0.24%
Metric Mean Median Stdev
Overall 1.6% 0.86% 4.61%
Up 3.2% 2.23% 3.43%
Down -1.57% -1.32% 1.54%
5D Opportunity: SELL-APPROACHING
returns: 3.64% (6.63%), p.close: 183.9
entry: 196.09, exit: 193.97, return: 1.08%
Metric Mean Median Stdev
Overall 0.05% -0.24% 5.94%
Up 2.56% 1.15% 3.12%
Down -2.55% -1.62% 3.93%
5D Opportunity: SELL-APPROACHING
returns: 3.64% (5.68%), p.close: 183.9
entry: 194.34, exit: 194.38, return: -0.02%
Metric Mean Median Stdev
Overall 0.28% 0.04% 4.46%
Up 2.04% 1.06% 2.54%
Down -1.78% -1.15% 2.96%
5D Opportunity: SELL-APPROACHING
returns: 3.64% (4.58%), p.close: 183.9
entry: 192.32, exit: 192.18, return: 0.08%
Metric Mean Median Stdev
Overall 0.32% 0.35% 3.87%
Up 1.97% 1.27% 2.26%
Down -1.64% -0.98% 2.52%
5D Opportunity: SELL-APPROACHING
returns: 3.64% (4.22%), p.close: 183.9
entry: 191.67, exit: 191.66, return: 0.0%
2W window
Metric Mean Median Stdev
Overall 6.73% 7.96% 5.76%
Up 7.16% 8.01% 5.57%
Down -1.87% -1.68% 1.56%
2W Opportunity: SELL-APPROACHING
returns: 11.92% (12.73%), p.close: 170.3
entry: 191.99, exit: 193.66, return: -0.87%
Metric Mean Median Stdev
Overall 1.57% -0.63% 6.36%
Up 3.9% 1.69% 4.82%
Down -2.72% -2.64% 1.93%
2W Opportunity: SELL-ACTIVE
returns: 11.92% (8.72%), p.close: 170.3
entry: 185.16, exit: 180.07, return: 2.75%
Metric Mean Median Stdev
Overall -0.27% 0.52% 7.89%
Up 3.98% 2.74% 4.05%
Down -4.27% -2.65% 5.4%
2W Opportunity: SELL-ACTIVE
returns: 11.92% (8.04%), p.close: 170.3
entry: 183.98, exit: 184.64, return: -0.35%
Metric Mean Median Stdev
Overall 0.46% 0.43% 6.1%
Up 3.35% 2.06% 3.48%
Down -2.86% -1.73% 4.16%
2W Opportunity: SELL-ACTIVE
returns: 11.92% (6.83%), p.close: 170.3
entry: 181.93, exit: 181.43, return: 0.27%
Metric Mean Median Stdev
Overall 0.53% 0.45% 5.21%
Up 3.11% 2.06% 3.08%
Down -2.56% -1.55% 3.45%
2W Opportunity: SELL-ACTIVE
returns: 11.92% (6.19%), p.close: 170.3
entry: 180.84, exit: 179.93, return: 0.5%
1M window
Metric Mean Median Stdev
Overall 1.2% 0.2% 3.47%
Up 4.18% 3.63% 2.05%
Down -3.5% -3.19% 1.88%
1M Opportunity: SELL-APPROACHING
returns: 5.83% (6.22%), p.close: 180.1
entry: 191.31, exit: 186.69, return: 2.41%
Metric Mean Median Stdev
Overall -2.32% -0.74% 6.36%
Up 4.61% 4.71% 3.09%
Down -7.12% -5.27% 5.71%
1M Opportunity: SELL-APPROACHING
returns: 5.83% (7.7%), p.close: 180.1
entry: 193.98, exit: 190.22, return: 1.94%
Metric Mean Median Stdev
Overall 0.78% 0.28% 6.91%
Up 5.21% 4.37% 4.11%
Down -4.36% -2.76% 4.99%
1M Opportunity: SELL-APPROACHING
returns: 5.83% (9.32%), p.close: 180.1
entry: 196.89, exit: 193.04, return: 1.96%
Metric Mean Median Stdev
Overall 0.89% 1.04% 6.37%
Up 4.74% 3.95% 3.67%
Down -3.96% -2.71% 4.33%
1M Opportunity: SELL-APPROACHING
returns: 5.83% (8.41%), p.close: 180.1
entry: 195.24, exit: 193.43, return: 0.93%

ABBV's symbol current price is 190.6 (0.0%) as on . Yesterday's close was 190.6. It's return velocities are computed basis data from date .

Win Percent
Key Weighted 5D 1M 3M 6M 1Y 3Y
Open-High (> 1.0%) 58.75% 80.0% 54.55% 34.85% 32.58% 34.52% 37.57%
Open-Low (> 1.0%) 33.48% 20.0% 45.45% 39.39% 41.67% 38.49% 36.38%
Open-Close-Up (> 0.5%) 53.18% 80.0% 36.36% 34.85% 31.82% 34.13% 34.52%
Open-Close-Down (> 0.5%) 28.16% 20.0% 36.36% 31.82% 28.79% 29.76% 27.78%
Low-Close-Up (> 1.0%) 50.53% 60.0% 45.45% 43.94% 41.67% 39.29% 42.2%
High-Close-Down (> 1.0%) 29.54% 20.0% 36.36% 36.36% 33.33% 34.52% 32.94%

ABBV's symbol win percent is computed basis data from date

Associated Tags